Epidemiology of invasive cutaneous melanoma
暂无分享,去创建一个
[1] M. Garmyn,et al. Melanoma screening: results of the first one‐day campaign in Belgium (‘Melanoma Monday’) , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] M. Haniffa,et al. The use of a spectrophotometric intracutaneous analysis device in the real‐time diagnosis of melanoma in the setting of a melanoma screening clinic , 2007, The British journal of dermatology.
[3] G. Colditz,et al. Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.
[4] F. Grange. Épidémiologie du mélanome cutané : données descriptives en France et en Europe , 2005 .
[5] A. Auvinen,et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study , 2002, BMJ : British Medical Journal.
[6] R. Millikan,et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[7] A. Halpern,et al. Reproductive risk factors for cutaneous melanoma in women: a case-control study. , 2006, American journal of epidemiology.
[8] C. Hollenbeak,et al. Increased incidence of melanoma in renal transplantation recipients , 2005, Cancer.
[9] Horton,et al. Annals of Oncology , 1991, Springer US.
[10] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[11] J. Aitken,et al. A randomised trial of population screening for melanoma , 2002, Journal of medical screening.
[12] J. Grob,et al. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. , 1998, Archives of dermatology.
[13] S. Leachman,et al. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma , 2006, Current opinion in oncology.
[14] E. White,et al. Melanoma risk by age and socio‐economic status , 1990, International journal of cancer.
[15] St,et al. Epidemiology and cancer registries in the Pacific Basin , 1977 .
[16] C. Garbe,et al. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001 , 2007, Cancer.
[17] F. D. de Gruijl,et al. Predictions of skin cancer incidence in the Netherlands up to 2015 , 2005, The British journal of dermatology.
[18] R. MacKie,et al. Audit of public education campaign to encourage earlier detection of malignant melanoma. , 1992, BMJ.
[19] Nils Homer,et al. Common sequence variants on 20q11.22 confer melanoma susceptibility , 2008, Nature Genetics.
[20] Sabine Siesling,et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. , 2008, European journal of cancer.
[21] M. Nicolson,et al. Melanoma incidence and mortality in Scotland 1979–2003 , 2007, British Journal of Cancer.
[22] F. Grange. [Epidemiology of cutaneous melanoma: descriptive data in France and Europe]. , 2005, Annales de dermatologie et de venereologie.
[23] S. Rosso,et al. Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis , 2006, Cancer Causes & Control.
[24] F. Wojnarowska,et al. Melanomas in renal transplant recipients , 2006, The British journal of dermatology.
[25] B. Armstrong,et al. Epidemiology of pre‐invasive and invasive malignant melanoma in Western Australia , 1980, International journal of cancer.
[26] S. Varma,et al. Audit of a melanoma screening day in the U.K.: clinical results, participant satisfaction and perceived value , 2001, The British journal of dermatology.
[27] M. Janssen-Heijnen,et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] H. Dal,et al. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? , 2007, European journal of dermatology : EJD.
[29] F. Sera,et al. MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.
[30] D. Whiteman,et al. A Risk Prediction Tool for Melanoma? , 2005, Cancer Epidemiology Biomarkers & Prevention.
[31] D. Duffy,et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. , 2001, American journal of human genetics.
[32] The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review , 2007, International journal of cancer.
[33] J. Aitken,et al. Increase in skin cancer screening during a community‐based randomized intervention trial , 2006, International journal of cancer.
[34] C. J. O'doherty,et al. Benign melanocytic naevi as a risk factor for malignant melanoma. , 1986, British medical journal.
[35] J. Coebergh,et al. Cutaneous malignant melanoma in Europe. , 2004, European journal of cancer.
[36] B. Armstrong,et al. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.
[37] R. Herings,et al. Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin? , 2007, European journal of cancer.
[38] H. Storm,et al. Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: a population-based cohort study , 1999, The Lancet.
[39] H. Kittler,et al. Diagnostic accuracy of dermoscopy. , 2002, The Lancet. Oncology.
[40] B. Diffey,et al. The future incidence of cutaneous melanoma within the U.K. , 2004, The British journal of dermatology.
[41] R. Gallagher,et al. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.
[42] R. MacKie,et al. Reasons for poor prognosis in British patients with cutaneous malignant melanoma. , 1986, British medical journal.
[43] Kari Stefansson,et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.
[44] Donald R. Miller,et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. , 2003, Journal of the American Academy of Dermatology.
[45] R. Stern,et al. Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.
[46] C. Ingvar,et al. Invasive cutaneous malignant melanoma in Sweden, 1990–1999 , 2004, Cancer.
[47] Westgate Road,et al. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic , 2007 .
[48] C. Lebbé,et al. A French CDK4-positive melanoma family with a co-inherited EDNRB mutation. , 2007, Journal of dermatological science.
[49] Paolo Carli,et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. , 2004, Journal of the American Academy of Dermatology.
[50] D. Hole,et al. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status , 1996, BMJ.
[51] K. Magnus,et al. Trends in Cancer Incidence: Causes and Practical Implications , 1981 .
[52] E. Bastiaannet,et al. No increase of melanoma after kidney transplantation in the northern part of The Netherlands , 2007, Melanoma research.
[53] R. MacKie,et al. Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma , 2004, British Journal of Cancer.
[54] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[55] M. Rademaker,et al. Extremely high levels of melanoma in Tauranga, New Zealand: Possible causes and comparisons with Australia and the northern hemisphere , 2007, The Australasian journal of dermatology.